JMJD2D Blocking Peptide (C-term)

JMJD2D Blocking Peptide (C-term)

€363.00
In stock
SKU
AC-BP1028b
Catalog Number: AC-BP1028b
Size: 500 µg
Datasheet
Request Information
Background:
Covalent modification of histones plays critical role in regulating chromatin structure and transcription. While most covalent histone modifications are reversible, only recently has it been established that methyl groups are subject to enzymatic removal from histones. A family of novel JmjC domain-containing histone demethylation (JHDM) enzymes have been identified that perform this specific function. Histone demethylation by JHDM proteins requires cofactors Fe(II) and alpha-ketoglutarate. Family members include JHDM1 (demethylating histone 3 at lysine 36), and JHDM2A as well as JMJD2CH3K9 (both of which demethylate histone 3 at lysine 9). Contributions of histone demethylase activity to tumor development, decreases in cell proliferation, and hormone-dependent transcriptional activation have been observed.

Other Names:
Lysine-specific demethylase 4D, 11411-, JmjC domain-containing histone demethylation protein 3D, Jumonji domain-containing protein 2D, KDM4D, JHDM3D, JMJD2D

Target/Specificity:
The synthetic peptide sequence is selected from aa 499-516 of HUMAN KDM4D

Gene Name: KDM4D

Gene ID: 55693
Primary Accession: Q6B0I6
Other Accession: Q0VF39
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:JMJD2D Blocking Peptide (C-term)